Product Information

DOXEPIN 100 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.3144 per EA under NDC 64980059801. Its NADAC has been published 130 times since May 29, 2024.

FDA first approved this application on Aug 21, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOXEPIN 100 MG CAPSULE

Doxepin hydrochloride
$0.3144per EA

Strength

100 mg/1

NDC

64980059801

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DOXEPIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA217975

FDA Approved

8/21/2023

TE Code

AB

On Market Since

12/25/2023

Pharmacological Classes

Price Statistics

The NADAC for DOXEPIN 100 MG CAPSULE has been published 130 times since May 29, 2024, and over the history we have for it it has risen 5.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3144 per EA
All-time high$0.4079 (Sep 11, 2024)
All-time low$0.2255 (Feb 19, 2025)
52-week high$0.3144
52-week low$0.2459
Median price$0.2669
Average price$0.2711
Largest weekly change+46.8% (Aug 21, 2024)
Weeks tracked130
Tracking sinceMay 29, 2024

Price History

1W

+4.2%

1M

+8.4%

3M

+17.8%

6M

+18.9%

1Y

+22.1%

3Y

N/A

5Y

N/A

All

+5.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DOXEPIN 100 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 100 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.3144 per EA (NDC 64980059801), effective Nov 18, 2026.

How has the price of DOXEPIN 100 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DOXEPIN 100 MG CAPSULE has risen 5.1%. It has been tracked across 130 weekly CMS publications since May 29, 2024.

What are the highest and lowest recorded NADAC prices for DOXEPIN 100 MG CAPSULE?

Since May 29, 2024, the NADAC for DOXEPIN 100 MG CAPSULE has ranged from a low of $0.2255 (Feb 19, 2025) to a high of $0.4079 (Sep 11, 2024), with a median of $0.2669 per EA.

Are there cheaper alternatives to DOXEPIN 100 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DOXEPIN 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures DOXEPIN 100 MG CAPSULE?

DOXEPIN 100 MG CAPSULE (NDC 64980059801) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.